Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506, USA.
J Anim Sci. 2012 May;90(5):1628-37. doi: 10.2527/jas.2011-4285. Epub 2011 Dec 6.
The objectives of this study were to determine the effects of supplementation with a single β-adrenergic agonist (β-AA) or a sequence of β-AA on cow performance, carcass characteristics, and mRNA relative abundance of cull cows implanted and fed a concentrate diet. Sixty cull cows were implanted with Revalor-200 (200 mg of trenbolone acetate and 20 mg of estradiol) and assigned to 1 of 4 treatments (n = 15/treatment): CON = fed a concentrate diet only; RH = supplemented with ractopamine-HCl for the last 25 d before slaughter; ZH = supplemented with zilpaterol-HCl for 20 d before a 3-d withdrawal before slaughter; RH + ZH = supplemented with RH for 25 d, followed by ZH for 20 d before a 3-d withdrawal before slaughter. Ractopamine-HCl was supplemented at a dose of 200 mg·animal(-1)·d(-1), and ZH was supplemented at 8.33 mg/kg (100% DM basis) of feed. All cows were fed a concentrate diet for 74 d. Each treatment had 5 cows per pen and 3 replicate pens. Body weights were collected on d 1, 24, 51, and 72. Muscle biopsies from the LM were collected on d 24, 51, and at slaughter from a subsample of 3 cows per pen. Carcass traits were evaluated postslaughter. The 2 ZH treatments averaged 15.3 kg more BW gain, 0.20 kg greater ADG, and 7.8 cm(2) larger LM area than CON and RH treatments, and 21 kg more HCW than CON, but these differences were not significant (P > 0.10), likely due to a sample size of n = 15/treatment. The sequence of RH followed by ZH tended to optimize the combination of HCW, LM area, percent intramuscular fat, and lean color and maturity compared with the ZH treatment. Abundance of β(2)-adrenergic receptor (AR) mRNA was not altered in the RH + ZH treatment during RH supplementation from d 24 to 51 of feeding. However, the abundance of β(2)-AR mRNA increased (P < 0.05) the last 23 d of feeding for the RH treatment and tended (P = 0.10) to increase in ZH cows during ZH supplementation. For all cows, abundance of type IIa myosin heavy chain (MHC-IIa) mRNA decreased (P < 0.05) after 24 d of feeding. Abundance of MHC-IIx mRNA increased (P < 0.05) for ZH and RH + ZH treatments the last 23 d of feeding during ZH supplementation. Although few significant differences were observed in performance or carcass traits, mRNA quantification indicated that β-AA supplementation elicited a cellular response in cull cows. Implanting and feeding cull cows for 74 d, regardless of β-AA supplementation, added economic value by transitioning cows from a cull cow to what is referred to in industry as a white cow market in which cows have white fat resulting from grain feeding.
本研究的目的是确定单一β-激动剂(β-AA)或β-AA 序列补充对奶牛生产性能、胴体特性和被植入并饲喂浓缩饲料的淘汰牛的 mRNA 相对丰度的影响。60 头淘汰牛被植入 Revalor-200(200mg 醋酸去甲雄三烯醇酮和 20mg 雌二醇),并被分配到 4 种处理中的 1 种(n = 15/处理):CON = 仅饲喂浓缩饲料;RH = 在屠宰前最后 25d 补充莱克多巴胺盐酸盐;ZH = 在屠宰前 20d 补充齐帕特罗盐酸盐,然后停药 3d;RH + ZH = 在补充 RH 25d 后,再补充 ZH 20d,然后停药 3d。莱克多巴胺盐酸盐的补充剂量为 200mg·动物(-1)·d(-1),ZH 以 8.33mg/kg(100%DM 基础)的饲料补充。所有奶牛均饲喂浓缩饲料 74d。每个处理有 5 头奶牛/栏,3 个重复栏。在第 1、24、51 和 72d 收集体重。在第 24、51 和屠宰时从每栏的 3 头奶牛中采集背最长肌肌肉活检。屠宰后评估胴体性状。2 个 ZH 处理的平均 BW 增重比 CON 和 RH 处理高 15.3kg,ADG 高 0.20kg,LM 面积大 7.8cm2,HCW 比 CON 高 21kg,但这些差异不显著(P>0.10),可能是因为处理 n = 15/处理的样本量小。与 ZH 处理相比,RH 随后补充 ZH 倾向于优化 HCW、LM 面积、肌肉内脂肪百分比和瘦肉颜色和成熟度的组合。在 RH 补充的第 24 至 51d 期间,RH + ZH 处理中β(2)-肾上腺素能受体(AR)mRNA 的丰度没有改变。然而,在 RH 处理的最后 23d 饲喂期间,β(2)-AR mRNA 的丰度增加(P<0.05),在 ZH 奶牛中也有增加的趋势(P = 0.10)。对于所有奶牛,在饲喂 24d 后,IIa 型肌球蛋白重链(MHC-IIa)mRNA 的丰度降低(P<0.05)。在 ZH 和 RH + ZH 处理中,在 ZH 补充的最后 23d 饲喂期间,MHC-IIx mRNA 的丰度增加(P<0.05)。尽管在性能或胴体性状方面观察到的差异很少,但 mRNA 定量分析表明,β-AA 补充在淘汰牛中引起了细胞反应。在 74d 内植入和饲喂淘汰牛,无论是否补充 β-AA,都通过将奶牛从淘汰牛转变为行业中所谓的白牛市场来增加经济价值,在白牛市场中,奶牛的白色脂肪是由谷物喂养产生的。